Next Generation Molecular Modeling

The evolution of artificial intelligence (AI) allows calculation of complex and large sets of data to be done in an unprecedented short period of time. The application of AI in drug discovery has become popular recently.

In Synovel Laboratory, we incorporate AI into our molecular modeling and fragment based virtual screening. This new feature shortens the time needed for the calculation of potential fragments and conformations exponentially.

Currently we have 3 focus Fragment based libraries with AI enhancements available to use for novel drug discovery projects:

• Fragment Based Virtual Screening Library

• Peptide Based Virtual Screening Library

• Target Protein Degradation Screening Library